HNN3.0

Project cooperationUpdated on 19 January 2026

New Approach Methodologies: patient-derived iPSC models

full professor at Department of Pharmaceutical Sciences, University of Latvia

Riga, Latvia

About

We have expertise in patient-derived iPSC generation and differentiation into skeletal myoblasts and myotubes for rare muscular dystrophies, including LGMDR1. Our work focuses on preclinical disease modelling to support personalised therapeutic development. We seek participation in a Horizon Europe consortium developing antisense oligonucleotide or base-editing approaches for rare inherited muscle diseases, contributing relevant cellular models for target validation and preclinical testing.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities